Estimated Cancer Incidence in Northern Tunisia in 2023: Northern Tunisia Cancer Registry.

Q2 Medicine
Houyem Khiari, Emna Arfaoui, Najet Mahjoub, Soumaya Henchiri, Alyssa Sliti, Mohamed Hsairi
{"title":"Estimated Cancer Incidence in Northern Tunisia in 2023: Northern Tunisia Cancer Registry.","authors":"Houyem Khiari, Emna Arfaoui, Najet Mahjoub, Soumaya Henchiri, Alyssa Sliti, Mohamed Hsairi","doi":"10.31557/APJCP.2024.25.12.4359","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cancer is a major cause of morbidity and mortality in Tunisia. The objectives of our study were to estimate the incidence level of the main cancer sites in Northern Tunisia in 2023 and to dress projections till 2040.</p><p><strong>Methods: </strong>The population based cancer registry database of northern Tunisia was the source of cases of this study. This registry uses the active method to collect data from all health services that cover cancer patients of both public and private sectors. Incidence rate projections were established using the age-period-cohort model.</p><p><strong>Results: </strong>In 2023, according to our estimations, age standardized incidence rate (ASR) including skin cancers other than melanoma was of 165.9 /100,000 in males and 141.4/100,000 in females. In men, the five most common cancer locations (apart from the skin) were: lung with an ASR of 37.6/100,000 habitant, colorectal (29.4/100,000), bladder (24.1/100,000), prostate (15.2/100,000) and stomach (6.0/100,000). Concerning females, the top five locations (apart from the skin) were: breast (55.4/100,000), colorectal (23.0/100,000), corpus uteri (9.3/100,000), thyroid (9.0/100,000) and lung (5.8/100,000). By 2040, the incidence rates of colorectal cancer would reach more than the double in both genders. The ASR of lung and bladder cancers in males would be increasing; however, that of stomach cancer would be stable next decades. In females, while incidence rates of breast, thyroid and corpus uteri cancers would reach more than the double in 2040, cervical cancer incidence is expected to be stable next decades.</p><p><strong>Conclusion: </strong>Cancer incidence level in Northern Tunisia place the country in an intermediate level and projections seem to be worrying. Strengthening prevention, screening and early diagnosis are strongly recommended.</p>","PeriodicalId":55451,"journal":{"name":"Asian Pacific Journal of Cancer Prevention","volume":"25 12","pages":"4359-4369"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Pacific Journal of Cancer Prevention","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31557/APJCP.2024.25.12.4359","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Cancer is a major cause of morbidity and mortality in Tunisia. The objectives of our study were to estimate the incidence level of the main cancer sites in Northern Tunisia in 2023 and to dress projections till 2040.

Methods: The population based cancer registry database of northern Tunisia was the source of cases of this study. This registry uses the active method to collect data from all health services that cover cancer patients of both public and private sectors. Incidence rate projections were established using the age-period-cohort model.

Results: In 2023, according to our estimations, age standardized incidence rate (ASR) including skin cancers other than melanoma was of 165.9 /100,000 in males and 141.4/100,000 in females. In men, the five most common cancer locations (apart from the skin) were: lung with an ASR of 37.6/100,000 habitant, colorectal (29.4/100,000), bladder (24.1/100,000), prostate (15.2/100,000) and stomach (6.0/100,000). Concerning females, the top five locations (apart from the skin) were: breast (55.4/100,000), colorectal (23.0/100,000), corpus uteri (9.3/100,000), thyroid (9.0/100,000) and lung (5.8/100,000). By 2040, the incidence rates of colorectal cancer would reach more than the double in both genders. The ASR of lung and bladder cancers in males would be increasing; however, that of stomach cancer would be stable next decades. In females, while incidence rates of breast, thyroid and corpus uteri cancers would reach more than the double in 2040, cervical cancer incidence is expected to be stable next decades.

Conclusion: Cancer incidence level in Northern Tunisia place the country in an intermediate level and projections seem to be worrying. Strengthening prevention, screening and early diagnosis are strongly recommended.

2023 年突尼斯北部癌症发病率估计:突尼斯北部癌症登记处。
背景:癌症是突尼斯发病率和死亡率的主要原因。我们研究的目的是估计2023年突尼斯北部主要癌症部位的发病率水平,并预测到2040年。方法:本研究以突尼斯北部人口为基础的癌症登记数据库为病例来源。该登记处采用主动方法从涵盖公共和私营部门癌症患者的所有卫生服务部门收集数据。发病率预测采用年龄-时期-队列模型。结果:2023年,根据我们的估计,包括黑色素瘤以外的皮肤癌在内的年龄标准化发病率(ASR)男性为165.9 /10万,女性为141.4/10万。在男性中,五个最常见的癌症部位(除了皮肤)是:肺癌(ASR为37.6/100,000)、结直肠癌(29.4/100,000)、膀胱(24.1/100,000)、前列腺(15.2/100,000)和胃(6.0/100,000)。女性除皮肤外,前5位依次为:乳房(55.4/10万)、结直肠(23.0/10万)、子宫(9.3/10万)、甲状腺(9.0/10万)和肺(5.8/10万)。到2040年,男女结直肠癌的发病率将达到两倍以上。男性肺癌和膀胱癌的ASR会增加;然而,在接下来的几十年里,胃癌的发病率将是稳定的。在女性中,虽然乳腺癌、甲状腺癌和子宫癌的发病率在2040年将达到两倍以上,但宫颈癌的发病率预计在未来几十年将保持稳定。结论:突尼斯北部的癌症发病率水平使该国处于中等水平,预测似乎令人担忧。强烈建议加强预防、筛查和早期诊断。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.80
自引率
0.00%
发文量
779
审稿时长
3 months
期刊介绍: Cancer is a very complex disease. While many aspects of carcinoge-nesis and oncogenesis are known, cancer control and prevention at the community level is however still in its infancy. Much more work needs to be done and many more steps need to be taken before effective strategies are developed. The multidisciplinary approaches and efforts to understand and control cancer in an effective and efficient manner, require highly trained scientists in all branches of the cancer sciences, from cellular and molecular aspects to patient care and palliation. The Asia Pacific Organization for Cancer Prevention (APOCP) and its official publication, the Asia Pacific Journal of Cancer Prevention (APJCP), have served the community of cancer scientists very well and intends to continue to serve in this capacity to the best of its abilities. One of the objectives of the APOCP is to provide all relevant and current scientific information on the whole spectrum of cancer sciences. They aim to do this by providing a forum for communication and propagation of original and innovative research findings that have relevance to understanding the etiology, progression, treatment, and survival of patients, through their journal. The APJCP with its distinguished, diverse, and Asia-wide team of editors, reviewers, and readers, ensure the highest standards of research communication within the cancer sciences community across Asia as well as globally. The APJCP publishes original research results under the following categories: -Epidemiology, detection and screening. -Cellular research and bio-markers. -Identification of bio-targets and agents with novel mechanisms of action. -Optimal clinical use of existing anti-cancer agents, including combination therapies. -Radiation and surgery. -Palliative care. -Patient adherence, quality of life, satisfaction. -Health economic evaluations.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信